StockWatch
·

Eureka Forbes Ltd

BSE: 543482

P/L Snapshot

Q2 FY27 · standalone

vs Q1 FY27·vs Q2 FY26
Revenue
895.70
+26.5%+14.9%
Expenditure
797.61
+22.1%+14.6%
Net Profit
73.34
+32.3%+19.1%
OPM %
12.82%
+0.42pp+0.43pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.00250.80501.59752.391.0KQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Price Chart
Reports

Growth Reaccelerated, but Margins Are in Inflation's Grip

appliances · water-purifier · robotics

Result verdictFollow-upQ2 FY2709 Nov 20266 minConsumer & Retail

Growth acceleration sustained; margin pressure to ease post-pricing

revenue growth 15% YoY · emerging categories acceleration · margin pressure inflation

TranscriptDeep diveQ2 FY2709 Nov 20266 minConsumer & Retail

Eureka Forbes Q2 FY27: consolidated PAT +17.8% YoY to ₹74 Cr, margins expand to 12.9%

margin expansion · revenue growth · water purifiers

ResultsQ2 FY2702 Nov 20263 minConsumer & Retail
Latest
Board Meeting2 Nov, 1:42 pm

Eureka Forbes Q2 FY27: consolidated PAT +17.8% YoY to ₹74 Cr, margins expand to 12.9%

Eureka Forbes posted a broad-based beat in Q2 FY27. Consolidated revenue rose 15.1% YoY to ₹888.5 Cr (+26.9% QoQ, seasonally aided — not the headline) and consolidated PAT grew 17.8% YoY to ₹74.1 Cr (standalone PAT ₹73.3 Cr, EPS ₹3.77 vs consolidated EPS ₹3.81 — the two bases track closely, no material divergence). Both metrics ran well ahead of our pre-result Street preview, which had pencilled in revenue of ₹700-750 Cr, EBITDA margin near 12%, and PAT of ₹45-50 Cr; the actual print cleared the top end of every one of those ranges, with PAT roughly 48-65% above the guided range. The margin story is the more important half of the beat. Operating margin expanded to 12.94% from 12.65% a year ago and 12.70% last quarter, while net margin rose to 8.28% from 8.09% YoY — profit grew faster than revenue both YoY and QoQ. This goes beyond management's own guidance from the last call, which had called for FY27 EBITDA margins merely "broadly in line with FY26" given commodity and forex headwinds; instead the quarter shows margin expansion on both comparisons, with no exceptional items distorting the print (unlike Q1 FY27, whose ₹19.5 Cr one-off gratuity-reversal gain inflates the sequential base, making the +30% QoQ PAT move a weaker read than the clean +17.8% YoY number). The print also lands alongside resolution of a GST overhang: the ₹273.4 Cr show-cause notice received September 28 was rectified down to ₹4.5 Cr on October 1, just ahead of results, removing a contingent liability that had been a live pre-result concern. Less resolved is the promoter pledge, which rose to 11.53% of holding on September 22 — a balance-sheet/ownership signal this filing doesn't address and that stays on watch. The filing carries no segment breakout (Health & Hygiene is reported as a single segment under Ind AS 108), so the preview's ~43% water-purifier revenue-mix marker can't be verified from these numbers, and no management press release was available in the filing to cross-check against the print. With revenue growth accelerating and margins already ahead of the "in-line" bar management set last call, the quarter validates the "step-up in growth" management flagged more convincingly than it validates caution on margins. The open question for Q3 is whether the 12.9% OPM holds without the cushion of a clean, exceptional-free quarter, and whether the water-purifier mix continues to do the work management expects of emerging categories.

2 Nov 2026, 01:42 pm

Corporate Events

Board MeetingEUREKAFORB
2026
2Nov

Board Meeting

The Board of Directors meeting is scheduled to consider and …

BSE Filing ↗
Board MeetingEUREKAFORB
2026
19Aug

Board Meeting

The 17th Annual General Meeting ("AGM") of Eureka Forbes Lim…

BSE Filing ↗
Board MeetingEUREKAFORB
2026
12Aug

Board Meeting

The meeting of the Board of Directors will be held to consid…

BSE Filing ↗
Board MeetingEUREKAFORB
2026
4Feb

Board Meeting

Approval of Unaudited Standalone and Consolidated Financial …

BSE Filing ↗
Board MeetingEUREKAFORB
2025
11Aug

Board Meeting

Approval of Unaudited Standalone and Consolidated Financial …

BSE Filing ↗
Board MeetingEUREKAFORB
2025
10Feb

Board Meeting

Approve Unaudited Standalone and Consolidated Financial Resu…

BSE Filing ↗
Board MeetingEUREKAFORB
2024
7Nov

Board Meeting

Considering And Approving The Unaudited Standalone And Conso…

BSE Filing ↗
Board MeetingEUREKAFORB
2024
8Aug

Board Meeting

Consider and approve the Unaudited Standalone and Consolidat…

BSE Filing ↗
Board MeetingEUREKAFORB
2024
28May

Board Meeting

Consider and approve Audited Standalone and Consolidated Fin…

BSE Filing ↗
Board MeetingEUREKAFORB
2024
14Feb

Board Meeting

consider and approve Unaudited Standalone and Consolidated F…

BSE Filing ↗
Board MeetingEUREKAFORB
2023
10Nov

Board Meeting

Consider and approve the Unaudited Standalone and Consolidat…

BSE Filing ↗
Board MeetingEUREKAFORB
2023
8Aug

Board Meeting

Consideration of Financial Results for the Quarter ended Jun…

BSE Filing ↗